You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TSC1

Showing 1 - 25 of 209
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Solid Tumors Trial (Sirolimus for Injection (Albumin-bound))

Not yet recruiting
  • Malignant Solid Tumors
  • Sirolimus for Injection (Albumin-bound)
  • (no location specified)
Aug 19, 2022

Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,

Not yet recruiting
  • Head and Neck Cancer
  • +20 more
  • TSC-204-A0201
  • +4 more
  • Scottsdale, Arizona
  • +1 more
Aug 3, 2023

AML, MDS, ALL, Adult Trial in Hackensack, New York (SOC + TSC-100, SOC + TSC-101, Control)

Recruiting
  • AML
  • +2 more
  • SOC + TSC-100
  • +2 more
  • Hackensack, New Jersey
  • +1 more
Aug 11, 2022

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

PEComa, Malignant, TSC1, TSC2 Trial (ABI-009)

Approved for marketing
  • PEComa, Malignant
  • +3 more
  • (no location specified)
Mar 2, 2022

TSC1, TSC2, Tuberous Sclerosis Complex Trial in Boston, New York (Everolimus)

Completed
Has Results
  • TSC1
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 14, 2020

HIV/AIDS, Trauma Trial in Boston, Toronto (CBT-TSC, Life Steps and Sexual Decision-Making)

Completed
  • HIV/AIDS
  • Trauma
  • CBT-TSC
  • Life Steps and Sexual Decision-Making
  • Boston, Massachusetts
  • +1 more
Apr 7, 2023

Cancer of Stomach Trial in Seoul (AZD2014)

Terminated
  • Cancer of Stomach
  • Seoul, Korea, Republic of
    Samsung Medical Center
May 17, 2019

Solid Tumor Trial in Seoul (Vistusertib(AZD2014))

Withdrawn
  • Solid Tumor
  • Seoul, Korea, Republic of
    Samsung Medical Center
May 17, 2019

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +17 more
  • Biopsy
  • +3 more
  • Augusta, Georgia
  • +4 more
Jan 25, 2023

Studies in Patients With Tuberous Sclerosis Complex

Recruiting
  • Tuberous Sclerosis Complex
    • Phoenix, Arizona
      Translational Genomics Research Institute (TGen)
    Oct 18, 2022

    Tuberous Sclerosis, Lymphangioleiomyomatosis Trial in Canada, United States (procedure, genetic, other)

    Recruiting
    • Tuberous Sclerosis
    • Lymphangioleiomyomatosis
    • Phlebotomy
    • +3 more
    • Birmingham, Alabama
    • +22 more
    Jan 6, 2023

    Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)

    Recruiting
    • Lymphangioleiomyomatosis
    • Tuberous Sclerosis Complex
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 20, 2022

    Tuberous Sclerosis Trial in United States (Ganaxolone)

    Completed
    • Tuberous Sclerosis
    • Los Angeles, California
    • +6 more
    Oct 27, 2022

    Tuberous Sclerosis Complex, Epilepsy Trial in United States (Sirolimus, Placebo)

    Recruiting
    • Tuberous Sclerosis Complex
    • Epilepsy
    • Birmingham, Alabama
    • +7 more
    Sep 2, 2022

    Tuberous Sclerosis Complex Trial in Bristol (Acceptance and Commitment Therapy (ACT))

    Recruiting
    • Tuberous Sclerosis Complex
    • Acceptance and Commitment Therapy (ACT)
    • Bristol, United Kingdom
      University Hospitals Bristol and Weston NHS Trust
    May 10, 2023

    Recurrent Low Grade Astrocytoma, Recurrent WHO Grade 2 Glioma, Refractory Low Grade Astrocytoma Trial in Canada, United States

    Recruiting
    • Recurrent Low Grade Astrocytoma
    • +4 more
    • Quality-of-Life Assessment
    • +3 more
    • Birmingham, Alabama
    • +64 more
    Aug 20, 2022

    Tuberous Sclerosis Complex Trial in United States (Basimglurant with crossover to Placebo, Placebo with crossover to

    Recruiting
    • Tuberous Sclerosis Complex
    • Basimglurant with crossover to Placebo
    • Placebo with crossover to Basimglurant
    • Phoenix, Arizona
    • +47 more
    Jan 3, 2023

    Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

    Active, not recruiting
    • Hypomelanotic Macules
    • +8 more
      • Tirana, Albania
      • +7 more
      Mar 23, 2022

      Neurocutaneous Syndromes in Upper Egypt Children

      Not yet recruiting
      • Neurocutaneous Syndromes
        • (no location specified)
        Sep 10, 2023

        Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

        Recruiting
        • Advanced Malignant Solid Neoplasm
        • +44 more
        • Biopsy
        • +23 more
        • Birmingham, Alabama
        • +166 more
        Feb 2, 2023

        Healthy Subjects Trial in Overland Park (Trans-Sodium Crocetinate, Placebo)

        Completed
        • Healthy Subjects
        • Trans-Sodium Crocetinate
        • Placebo
        • Overland Park, Kansas
          Altasciences Clinical Kansas Inc
        Aug 20, 2021

        Tuberous Sclerosis Complex, Epilepsy Trial in Cincinnati (TAVT-18 (sirolimus))

        Active, not recruiting
        • Tuberous Sclerosis Complex
        • Epilepsy
        • TAVT-18 (sirolimus)
        • Cincinnati, Ohio
          Cincinnati Children's Hospital
        Jan 10, 2022

        Lymphangioleiomyomatosis Trial in Beijing (11C-Choline)

        Not yet recruiting
        • Lymphangioleiomyomatosis
        • Beijing, Dongcheng, China
          Peking union medical college hospital
        Oct 8, 2021

        Seizure in Participants With Tuberous Sclerosis Complex Trial in United States (GWP42003-P, SOC)

        Recruiting
        • Seizure in Participants With Tuberous Sclerosis Complex
        • Little Rock, Arkansas
        • +3 more
        Jul 6, 2022